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Purpose: This study aimed to comparatively evaluate the cost-effectiveness of four dif-
ferent types of radical nephrectomy (RN) techniques: open, laparoscopic, robot-assisted 
laparoscopic, and video-assisted minilaparotomy surgery (VAMS).
Materials and Methods: Among patients who were diagnosed with renal cell carcinoma 
and underwent RN, 20 patients were selected who received open, laparoscopic, ro-
bot-assisted laparoscopic, or VAMS RN between January 2008 and December 2010. 
Their medical fees were divided into four categories: procedure and operation, anes-
thesia, laboratory test, and medical supply fees. The medical costs of the patients were 
also divided into insured and uninsured costs. 
Results: The total direct cost of VAMS, open, laparoscopic, and robot-assisted laparo-
scopic RN were 2,023,791±240,757, 2,024,246±674,859 (p=0.998), 3,603,557±870,333
(p＜0.01), and 8,021,902±330,157 (p＜0.01) Korean Won (KRW, the currency of South 
Koea), respectively. The total insured cost of VAMS, open, laparoscopic, and robot-as-
sisted laparoscopic RN was 1,904,627±231,957, 1,798,127±645,602 (p=0.634), 3,039,769 
±711,792 (p＜0.01), and 899,668±323,508 (p＜0.01) KRW, respectively. The total un-
insured cost of VAMS, open, laparoscopic, and robot-assisted laparoscopic RN was 
119,163±24,581, 226,119±215,009, 563,788±487,798 (p＜0.01), and 7,122,234±56,117 (p
＜0.01) KRW, respectively. Medical supply fees accounted for the largest portion of the 
costs and amounted to 33.43% of the VAMS cost. 
Conclusions: VAMS RN is as cost-effective as open surgery. Furthermore, it is com-
paratively more cost-effective than laparoscopic and robot-assisted laparoscopic RN. 
Key Words: Cost analysis; Minimally invasive surgical procedures; Nephrectomy; Operative 
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INTRODUCTION 
Minimally invasive surgery was first described by 
Wickham [1] in 1987 and refers to surgical techniques that 
are less invasive than open surgery for the same purpose. 
Conventional open, laparoscopic, robot-assisted laparo-
scopic, and video-assisted minilaparotomy surgery (VAMS) 
have been performed as minimally invasive renal surgery. 
VAMS was conducted for the first time in 1991 for living 
donor nephrectomies [2]. This surgical technique was per-
formed through minilaparotomy and patients who under-
went it recovered quickly. More than 600 cases of living do-
nor nephrectomy have been conducted successfully, and 
this technique is also widely used to manage renal malig-
nancy [3,4]. 
Many studies have compared the cost-effectiveness of 
laparoscopic and robot-assisted renal surgeries with that 
of open surgery. Bolenz et al. [5] compared the costs of open 
surgery and robot-assisted laparoscopic radical prostatec-
tomy for prostate cancer. They noted that robot-assisted 
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laparoscopic prostatectomy was more expensive than open 
surgery in terms of medical supply and operation costs. 
Hamidi et al. [6] reported that laparoscopic living donor 
nephrectomy with low complication rates was a cost-effec-
tive renal surgery. However, there has been no research on 
the cost-effectiveness of minilaparotomy kidney surgeries 
such as VAMS. Therefore, this study aimed to compare the 
cost-analysis of VAMS versus open, laparoscopic, and ro-
bot-assisted laparoscopic radical nephrectomy (RN) sur-
gery under Korean medical insurance. 
MATERIALS AND METHODS
Twenty patients with suspected renal cell carcinoma who 
underwent VAMS, open, laparoscopic, or robot-assisted 
laparoscopic RN between January 2008 and December 
2010 were selected. The patients sampled for this study 
were treated between 2008 and 2010 while the insurance 
system applied, and the most recent 20 cases not subject 
to the exclusion criteria were selected.
Patients who met the following criteria were excluded: 1) 
those who underwent another surgery apart from RN, 2) 
those who incurred additional medical fees owing to post-
operative complications, 3) those who underwent RN during 
hospitalization in another department, and 4) those whose 
final pathological finding was not renal cell carcinoma. 
Patient information (age, gender, body mass index 
[BMI], and length of hospital stay) was retrospectively col-
lected from medical records. Tumor size was based on re-
ports from pathologists after the patients underwent RN. 
Tumor stage was based on the American Joint Committee 
on Cancer Tumor, Nodes, Metastasis staging, 7th edition 
[7]. 
Detailed cost information was collected from the Billing 
Department and the Medical Information Center. Cost in-
formation was based on itemized statements of patient 
medical service fees. Four items considered to be related 
to the surgery were compared from the itemized state-
ments: procedure and operation, anesthesia, laboratory 
testing, and medical supply fees. Items such as room and 
meal charges and medications, which were regarded as be-
ing minimally related to surgery, were excluded.
Procedure and operation fees refer to the costs of man-
agement and surgery. Management refers to surgical man-
agement, enemas, etc. Surgery was defined as a medical 
service directly performed by doctors with their hands or 
tools. Laboratory test fees refer to costs associated with ex-
tracting and testing specimens to diagnose a disease or as-
certain its progression. Anesthesia fees refer to the costs 
of anesthesia for a surgery or treatment associated with al-
leviating pain. Medical supplies refer to the costs of materi-
als used in a test or a surgery. Criteria for insured and un-
insured costs were based on benefit coverage criteria pre-
scribed by the Health Insurance Review and Assessment 
Service. For laparoscopic RN, routine disposable laparo-
scopic equipment was used. For robot-assisted laparo-
scopic RN, the da Vinci robot (Intuitive Surgical Inc., 
Sunnyvale, CA, USA) was used. VAMS was performed by 
use of a standardized surgical technique [4]. 
All statistical analyses were made by use of the IBM 
SPSS ver. 18.0 (IBM Co., Armonk, NY, USA). To determine 
the significance of the differences observed between the 
means of continuous variables, Student’s t-test was used. 
To determine the significance of the differences observed 
between the rates of categorical variables, Fisher’s exact 
test was used. A p-value less than 0.05 was considered stat-
istically significant. 
RESULTS
There was a significant difference in patient age and BMI 
(p＜0.05) between the laparoscopic and the VAMS group. 
There was no significant difference in tumor sizes or stage 
distributions between the VAMS group and the other three 
groups (Table 1).
Patient costs (mean±standard deviation) were 2,023,791± 
240,757, 2,024,246±674,859, 3,603,557±870,333, and 
8,021,902±330,157 Korean Won (KRW, the currency of 
South Koea) for the VAMS, open, laparoscopic, and ro-
bot-assisted RN groups, respectively. Among them, the 
sum of the insured costs was 1,904,627±231,957, 
1,798,127±645,602 (p=0.634), 3,039,769±711,792 (p＜0.01), 
and 899,668±323,508 (p＜0.01) KRW in the VAMS, open, 
laparoscopic, and robot-assisted RN groups, respectively, 
whereas the sum of the uninsured costs was 119,163± 
24,581, 226,119±215,009, 563,788±487,798 (p＜0.01), and 
7,122,234±56,117 (p＜0.01) KRW, respectively (Table 2). 
In the VAMS group, medical supply fees accounted for 
the highest portion of total costs at 38.63% (insured costs 
were 33.43% and uninsured costs were 5.20%), followed by 
procedure and operation fees at 29.99% (insured costs were 
29.99%). Procedure and operation fees in the open RN 
group, medical supply fees in the laparoscopic RN group, 
and procedure and operation fees in the robot-assisted lap-
aroscopic RN group accounted for the largest percent at 
33.19% (insured cost at 33.19%), 60.51% (insured cost at 
45.3% and uninsured cost at 15.08%), and 88.24% (insured 
cost at 0.98% and uninsured cost at 87.26%), respectively 
(Fig. 1).
There was a significant difference between the VAMS 
and open RN groups in the laboratory test (insured) and 
surgical material fees (insured and uninsured; p＜0.05). 
Medical supply fees were the item with the greatest dif-
ference between the laparoscopic and the VAMS groups 
(p＜0.05). There was likewise a significant difference be-
tween the groups in terms of laboratory test fees (insured; 
p＜0.05). In the robot-assisted laparoscopic RN group, 
procedure and operation fees had the greatest difference 
compared with those of the VAMS group. Laboratory 
test costs (insured) and medical supply costs (insured) 
were also significantly different from those of the 
VAMS group (p＜0.05). 
There was no significant difference in total cost between 
the VAMS and the open RN groups (p=0.998). There was 
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TABLE 2. Comparison by each surgical procedure category
Insurance
Open Laparoscopic Robot-assisted VAMS
Mean±SD p-valuea Mean±SD p-valuea Mean±SD p-valuea Mean±SD
Procedure and 
operation
Anesthesia
Laboratory 
test
Medical 
supplies
Sum
Total costb
Insured
Uninsured
Insured
Uninsured
Insured
Uninsured
Insured
Uninsured
Insured
Uninsured
   671,820±162,325
  0
   390,892±103,137
   3,256±4,645
   411,988±175,486
 10,150±8,701
   323,428±296,102
   212,713±214,634
1,798,127±645,602
   226,119±215,009
2,024,247±674,860
0.090
 
0.594
0.260
＜0.001
0.354
＜0.001
0.038
0.503
0.033
0.998
   631,846±173,522
  0
 418,207±98,735
   4,558±6,054
   352,750±209,478
   15,716±22,788
1,636,966±339,529
   543,514±490,640
3,039,769±711,792
   563,788±487,798
3,603,558±870,334
0.530
 
0.118
0.634
0.037
0.162
＜0.001
＜0.001
＜0.001
＜0.001
＜0.001
      78,684±167,068
7,000,000
  415,156±84,537
    9,551±6,235
    347,471±113,310
    15,716±22,788
    58,357±85,657
    97,057±40,260
    899,668±323,508
7,122,234±56,117
 8,021,902±330,158
＜0.01
 
0.108
0.096
＜0.001
0.160
＜0.001
0.431
＜0.001
＜0.001
＜0.001
 606,957±10,880
  0
 376,372±62,960
   5,643±8,103
 244,759±55,315
8,300
   676,539±186,448
 105,220±21,738
1,904,627±231,957
 119,163±24,581
2,023,791±240,757
VAMS, video-assisted minilaparotomy surgery.
a:Compared with VAMS, b:Total cost=insured cost＋uninsured cost.
TABLE 1. Patient characteristics
     Characteristic
Open Laparoscopic Robot-assisted VAMS
Frequency p-valueb Frequency p-valueb Frequency p-valueb Frequency
Number
Operation date
Mean age (yr)
Male gender (%)
BMI (kg/m2)
Tumor sizea (cm)
Stage
1
2
3
4
Length of stay (d)
20
Oct. 5-Oct. 12
56.9±12.4
70
23.6±3
7.91±4.1
 
6
6
7
1
8±2.3
 
 
0.171
0.465
0.692
0.067
0.196
 
 
  
 
0.002
20
Aug. 4-Oct. 12
60.15±11.5
60
   25±2.2
6.86±2.5
 
  7
  7
  6
  0
  7.4±2.8
 
 
0.028
0.288
0.032
0.221
0.266
 
 
 
 
0.034
20
Oct. 4-Oct. 12
  55.3±11.7
80
24.2±2.9
4.71±2.2
 
13
  5
  2
  0
     6±1.5
 
 
0.324
1
0.275
0.177
0.887
 
 
 
 
0.5
20
Oct. 2-Oct. 11
51.45±12.6
80
23.2±2.9
  5.8±2.8
 
12
  5
  3
  0
  5.6±2.1
Values are presented as mean±standard deviation.
BMI, body mass index; VAMS, video-assisted minilaparotomy surgery.
a:Tumor size was measured from the specimen, b:Compared with VAMS.
a significant difference in the sum of insured costs, un-
insured costs, and total costs between the VAMS and the 
laparoscopic RN group (p＜0.01). 
DISCUSSION
With patients placing importance on quality of life and de-
creased postoperative pain, demand for minimally in-
vasive surgery is increasing. Furthermore, along with the 
development of imaging and operative equipment, surgical 
techniques have undergone much improvement. 
Four minimally invasive surgical techniques are being 
used for kidney surgery in the urological field: laparoscopic 
surgery, minilaparotomy surgery, robot-assisted laparo-
scopic surgery, and percutaneous cryotherapy or ablation 
therapy. In 1990, Clayman et al. [8] reported on a laparo-
scopic nephrectomy performed on humans for the first 
time. This surgical technique, compared with conventional 
open surgery, caused less postoperative pain and required 
a shorter hospital stay and time to return to normal life [9]. 
In 2001, Guillonneau et al. [10] reported robot-assisted lap-
aroscopic nephrectomy on a non-functioning hydronephrotic 
kidney. Subsequently, other studies reported good func-
tional and oncologic outcomes in patients undergoing this 
surgical technique [10,11]. For the minilaparotomy techni-
que, Yang et al. [12] reported the first living donor neph-
rectomy using VAMS, and since then, data on safety and 
clinical usefulness from more than 600 cases of neph-
rectomy have been reported [2,3]. Currently, VAMS is used 
for diverse renal surgeries including radical, partial, and 
living donor nephrectomies [4]. The clinical usefulness of 
percutaneous techniques has been verified by many re-
ports, but they have limits in that they are applied to se-
lected patient cases only [13]. 
Korean J Urol 2012;53:519-523
522 Park et al
FIG. 1. Percentage of total cost by category.
Conventional open, laparoscopic, robot-assisted laparo-
scopic, and VAMS have been performed for renal masses. 
VAMS is a minilaparotomy technique in which an endo-
scope is used and a technique of internal traction is applied 
with a piercing retractor. It is one of the minimally invasive 
techniques for renal surgery. It leaves minimal oper-
ation-related scars owing to the surgical window available 
through minilaparotomy [14,15]. 
For a certain surgical technique to become widely used, 
it should be associated with advantages in terms of cost-ef-
fectiveness, patient benefits, and postoperative outcomes. 
However, there has been no study on the cost-effectiveness 
of VAMS compared with other surgical techniques for RN. 
For comparison and analysis, we divided patients who 
were diagnosed with renal cell carcinoma and underwent 
RN into the open, laparoscopic, robot-assisted laparo-
scopic, and VAMS RN groups. To research the cost-effec-
tiveness of surgical techniques, it is necessary to evaluate 
complications from such procedures, because complica-
tions affect total cost. Therefore, only four direct cost items 
related to surgery were compared and analyzed: procedure 
and operation, anesthesia, laboratory testing, and medical 
supply costs. 
In this study, items such as room and meal charges re-
lated to the length of stay were excluded from the evalua-
tion of the cost-effectiveness of surgical techniques. In 
Korea, the cost of ward stay is approximately 10,000 KRW 
per day, which is inexpensive and therefore may lead to lon-
ger hospital stays. 
According to our study results, VAMS was more cost-ef-
fective than laparoscopic and robot-assisted laparoscopic 
RN (p＜0.01) (Table 2). The greatest difference in medical 
supply fees was between the VAMS and laparoscopic RN 
groups (p＜0.01). In Korea, changes in the benefit coverage 
criteria of health insurance in 2006 enabled medical supply 
fees in laparoscopic surgery to be covered by health 
insurance. However, such a difference between the two 
groups in medical supply fees was probably due to fees for 
the disposable device (e.g., Autosuture Multifire Endo GIA 
12 mm [Covidien plc, Dublin, Ireland]) that is currently 
used and which is expensive (more than 100,000 KRW). 
Disposable devices (e.g., Floseal Hemostatic Matrix 
[Baxter Healthcare Co., Hayward, CA, USA], Harmonic 
Scalpel [Ethicon Endo-Surgery, Cincinnati, OH, USA]) are 
expensive and are rarely used in open or VAMS RN. This 
increases the cost of laparoscopic and robot-assisted lapa-
roscopic RN, making them more expensive compared with 
the open or VAMS group.
Laboratory testing (insured) fees were less in the VAMS 
group than in the laparoscopic RN group (p=0.037), which 
is related to the shorter length of stay in the former group. 
Among the itemized costs, the greatest difference in pro-
duced and operation fees (uninsured) was between the 
VAMS and robot-assisted laparoscopic RN groups. 
In robot-assisted surgery, many reusable devices (e.g., 
Endowrist [Intuitive Surgical Inc., Sunnyvale, CA, USA]) 
were used. Those devices are reusable several times with 
cleansing and sterilization; thus, it was not feasible to 
charge this cost for each surgery. At most hospitals, the 
maintenance cost for reusable devices is included in the 
uniform procedure and operation fee. Disposable devices 
were not charged separately, and the cost was also included 
in the uniform fee. Therefore, the cost of medical supplies 
for the robot-assisted laparoscopic RN group can seem to 
be lower than the costs for other groups. Currently, the 
price of the da Vinci robot ranges from 1.5 to 1.75 million 
Dollars and maintenance costs from 112,000 to 150,000 
Dollars [16]. This is why procedure and operation fees are 
more expensive in the robot-assisted laparoscopic RN 
group than in the VAMS group. 
Laboratory test fees were greater in the open than in the 
VAMS group because of the former group’s longer length 
of hospital stay. The mean total costs of laboratory tests in 
the immediate postoperative 5 days were almost the same 
in all groups; after that period, the cost increase was pro-
portional to the length of hospital stay. Medical supply fees 
were greater in the VAMS group than in the open RN group. 
This is due to the use of an endoscope and a disposable de-
vice 12 mm Visiport Plus (Tyco Healthcare, Norwalk, USA) 
accompanying it. Nevertheless, there was no significant 
difference in the total cost between the open RN and VAMS 
groups. 
Judging from the study results thus far, VAMS seems to 
be more cost-effective than laparoscopic and robot-assisted 
laparoscopic surgeries. Comparison of VAMS with open 
surgery showed no significant differences in costs between 
them, proving that VAMS is a competitive modality in re-
nal minimally invasive surgery. 
However, our study had some limitations. First, it com-
pared only the direct costs of surgeries. In addition to direct 
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costs, Hamidi et al. [6] compared and analyzed social costs 
after discharge, including costs resulting from complica-
tions in laparoscopic donor nephrectomy. When a patient 
undergoes a surgery, other costs such as medication and 
room and meal charges are incurred in addition to the direct 
costs related to the surgery. Furthermore, patients may be 
subject to complications. After discharge, patients may in-
cur indirect costs such as sick leave, copayments for health 
care, and hiring fees for home work. Our study compared 
only costs directly related with surgery and therefore was 
unable to predict outcomes resulting from the incurrence 
of other costs. Also, our study’s VAMS was performed by 
two experienced surgeons. Surgeons who have not yet over-
come the associated learning curve tend to have higher 
complication rates than do experienced surgeons. In this 
study, the surgeries of the VAMS group were conducted by 
experienced surgeons, which suggests that their complica-
tion rates would not be significantly different from those 
of the patients who underwent an open surgery [15]. 
Therefore, itemized amounts that may be affected by com-
plications were excluded. Although the learning curve of 
VAMS is not very steep [17], it is not a common technique; 
therefore, a large-scale multi-center study is necessary. 
Finally, this study only examined RN, which does not rep-
resent all VAMS procedures. Recent medical advance-
ments, including abdominal ultrasonography, have re-
sulted in increased discovery rates of small renal masses 
[18]. The standard method for treating small renal masses 
is shifting from radical to partial nephrectomy [19]. To fully 
research the cost-effectiveness of VAMS from different as-
pects, studies on other surgical techniques such as partial 
nephrectomy and pyeloplasty in addition to RN are 
necessary. 
CONCLUSIONS
VAMS RN is as cost-effective as open surgery. Furthermore, 
the procedure has cost-effectiveness advantages compared 
with laparoscopic and robot-assisted laparoscopic RN. 
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